No Detail Found!

Comparative Analysis of Fluorescence in Situ Hybridization and Real Time Polymerase Chain Reaction in Diagnosis of Chronic Myeloid Leukemia.

Author(s)
Javaid Ali Department of Pathology, Combined Military Hospital, Pano Aqil, Pakistan
Saleem Ahmed Khan Department of Pathology, Army Medical College, Rawalpindi, Pakistan
Muhammad Ayyub Department of Pathology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Nadir Ali Department of Pathology, Combined Military Hospital, Peshawar, Pakistan
Nabeel Khan Afridi Department of Pathology, Combined Military Hospital, Gilgit, Pakistan
Shan e Rauf Department of Pathology, Combined Military Hospital, Thal, FATA, Pakistan
Abstract
Objective: To compare the sensitivity and specificity of fluorescence in situ hybridization (FISH) with real time polymerase chain reaction (RT-PCR) in the diagnosis of Chronic Myeloid Leukemia (CML). Study Design: A cross-sectional, analytical study. Place and Duration of Study: Haematology Department, Armed Forces Institute of Pathology, Rawalpindi, from January 2012 to February 2014. Methodology: A total number of 87 patients of CML were studied. The diagnosis was made on the basis of clinical history, peripheral blood and bone marrow aspiration. These patients were tested for the presence of BCR-ABL1 fusion gene by RT-PCR and FISH. About 5 ml of venous blood was collected, half was taken in heparin for FISH and half in ethylenediamine tetra-acetic acid (EDTA) for CBC and PCR. For FISH, cells were cultured for 24 hours in RPMI 1640 medium and evaluated using BX51 fluorescence microscope for dual fusion signal of yellow colour. Samples having 20 or more interphases positive for dual fusion signals were taken as positive. For PCR, RNA extraction was done by Tri-Reagent LS (MRC, USA) and cDNA was synthesized using reverse transcriptase and gene specific primer. RT-PCR was done on ABI-7500. The positive samples were identified when fluorescence exceeded threshold limit. Results of RT-PCR and FISH were compared. Results: Out of the 87 patients, 85 (97.7%) were PCR positive and 2 (2.3%) were PCR negative, whereas in FISH 83 (95.4%) were positive and 4 (4.5%) were negative. Sensitivity and specificity of FISH was 97.6% and 100%, respectively. Conclusion: FISH is a reliable supplementary method to PCR for detection of BCR-ABL1 fusion gene in the diagnosis of CML.
Publication Details
Page(s) 26-29
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 27, Issue: 1, Year: 2017

Request the full text from PASTIC

Keywords
Chronic myeloid leukemia. Fluorescence in situ hybridization. Myeloproliferative neoplasm. Polymerase chain reaction.
References
HoffbrandAV,CatovskyD,TuddenhamEGD,GreenAR, 2015.,Postgraduate haematology 483 -502
SandipAS., 2013.The treatment of chronic myeloid leukemia, data from Gujrat Cancer,Indian J Med Paediatr Oncol 34 189 -92
SwerdlowHS,HarrisNL,JaffeES, 2008.WHO classification of tumours of haematopoietic and lymphoid tissue, 16 -30
JohnPG,JohnF,GeorgeMR,FrixosP,BertilG,DanielAA, .,Wintrobes clinical hematology 2006 -30
KantarjianH,CortesJ,NiederhuberJE,ArmitageJO,DoroshowJH, 2013.s clinical oncology, -
MiraF,PatS.,JuniaVM,JhonMG, .Clinical features of CML,Hematologic malignancies: Myeloproliferative Disorders 59 -74
TashfeenS,AhmedS,AliN., 2014.Real time polymerase chain reaction in diagnosis of chronic myeloid leukemia,J Coll Physicians Surg Pak 14 190 -3
DaleyGQ,Van EttenRA,BaltimoreD., 1990.Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome,Science 247 824 -
DrukerBJ, 2008.Translation of the Philadelphia chromosome into therapy for CML,Blood 112 4808 -17
GoldmanJM, 2010.Chronic myeloid leukemia: A historical perspective,Semin Hematol 47 302 -11
GoldmanJM,Marin D, 2012.Is imatinib still an acceptable first-line treatment for CML in chronic phase,Oncology 26 901 -7
O'Brien,SG , Guilhot,F , Larson,RA , Gathmann,I , Baccarani,M , Cervantes,F, 2003.Imatinib compared with interferon and lowdose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia,N Engl J Med 348 994 -1004
LimTH,TienSL,LimP,LinAST, 2005.The incidence and patterns of BCR/ABL rearrangements in chronic myeloid leukaemia using fluorescence in situ hybridisation,Ann Acad Med 34 533 -8
JainPP,PariharM,AhmedR,AbrahamR,VishwabandyaA,GeorgeB, 2012.Fluorescence in situ hybridization patterns of BCR/ABL1 fusion in chronic myeloid leukemia at diagnosis,IJPM 55 347 -51
GleissnerB,RiederH,ThielE,FonatschC,JanssenLA,HeinzeB, 2001.Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: Reliability of RT-nested-PCR and comparison to cytogenetic data,Leukemia 15 1834 -40
JameelA,JamilSN, 2000.Clinico-pathological profile of chronic myeloid leukemia,JPMI 20 235 -8
SaadZU,ShakeebAY,YaseerJ, 2009.Overview of chronic myeloid leukemia patients in Pakistan in the pre-imitanib era,Asian Pacific J Cancer Prev 10 1 -2
GanesanTS,RassoolF,GuoAP,Th'ngKH,DowdingC,HibbinJA, 1986.Rearrangement of the BCR gene in Philadelphia chromosome-negative chronic myeloid leukemia,Blood 68 957 -60
ReenaRMZ,JuliaMMJ,SalwatiS,ZubaidahZ,HamidahNH,SharifahNA, 2006.Detection of BCR/ABL gene in chronic myeloid leukaemia. Comparison of fluorescence in situ hybridisation (FISH), conventional cytogenetics and polymerase chain reaction (PCR) techniques,Med Health 1 5 -13
BaoF,MunkerDM,LoweryC,MartinS,ShiR,VeillonDM, 2007.Comparison of FISH and quantitative RT-PCR for the diagnosis and follow-up of BCR-ABL-positive leukemias,Mol Diagn Ther 11 239 -45
0

Citations

0

Downloads

105

Views